Morris Sherman
- Hepatology top 0.01%
- Epidemiology top 0.02%
- Surgery top 0.2%
- Cancer Research top 0.1%
- Molecular Biology top 1%
- Co-authors
- Jordi BruixJosep M. LlovetRiccardo LencioniMaría ReigGregory J. GoresMichel BeaugrandMassimo ColomboErik Christensen
- Topics
- Liver Disease Diagnosis and Treatment (135 papers)Hepatitis B Virus Studies (96 papers)Hepatocellular Carcinoma Treatment and Prognosis (91 papers)
- Journals
- ScienceJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- CanadaUnited StatesSpain
In The Last Decade
Morris Sherman
202 papers receiving 31.2k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Hepatology 24.1k
- Epidemiology 17.2k
- Surgery 5.3k
- Cancer Research 4.5k
- Molecular Biology 4.5k
Countries citing papers authored by Morris Sherman
This map shows the geographic impact of Morris Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morris Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morris Sherman more than expected).
Fields of papers citing papers by Morris Sherman
This network shows the impact of papers produced by Morris Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morris Sherman. The network helps show where Morris Sherman may publish in the future.
Co-authorship network of co-authors of Morris Sherman
This figure shows the co-authorship network connecting the top 25 collaborators of Morris Sherman. A scholar is included among the top collaborators of Morris Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morris Sherman. Morris Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinomabreakdown → | 1259 |
| 2 | 16 | |
| 3 | 40 | |
| 4 | 102 | |
| 5 | 48 | |
| 6 | Management of Hepatocellular Carcinoma: An Update Δσbreakdown → | 6556 |
| 7 | 210 | |
| 8 | 1 | |
| 9 | 14 | |
| 10 | 40 | |
| 11 | 27 | |
| 12 | 5 | |
| 13 | 2 | |
| 14 | 28 | |
| 15 | 200 | |
| 16 | 65 | |
| 17 | 97 | |
| 18 | Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conferencebreakdown → | 3380 |
| 19 | Loss of serum HBV DNA and HBeAg and seroconversion following short-term (12 weeks) adefovir dipivoxil therapy in chronic hepatitis B: two placebo-controlled phase II studies. | 42 |
| 20 | 59 |
About Morris Sherman
Morris Sherman is a scholar working on Hepatology, Epidemiology and Cancer Research, having authored 203 papers that have together received 31.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (135 papers), Hepatitis B Virus Studies (96 papers) and Hepatocellular Carcinoma Treatment and Prognosis (91 papers). The work is most often cited by research in Hepatology (24.1k citations), Epidemiology (17.2k citations) and Cancer Research (4.5k citations). Morris Sherman has collaborated with scholars based in Canada, United States and Spain. Frequent co-authors include Jordi Bruix, Josep M. Llovet, Riccardo Lencioni, María Reig, Gregory J. Gores, Michel Beaugrand, Massimo Colombo, Erik Christensen, Andrew K. Burroughs and Luigi Pagliaro. Their work appears in journals such as Science, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.